Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting

NCT07208305 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
222
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Affiliated Hospital of Qinghai University